Richard Torbett
Richard Torbett serves as the chief executive of the Association of the British Pharmaceutical Industry (ABPI) and has voiced concerns about the falling investment in new treatments in the UK due to uncompetitive drug pricing and outdated assessment thresholds.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 2 | 4.50 | 0.08% | +0% | 67,886,011 | 56,267 | $2,700,000 | 2,238$ |
| Totals | 2 | 67,886,011 | 56,267 | $2,700,000 | 2,238$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Richard Torbett is the head of the Association of the British Pharmaceutical Industry who described Merck's decision as an incredible blow.
4
United Kingdom:
Richard Torbett is the chief executive of the ABPI who commented on the demand for innovative medicines and investment challenges.
5